JP2024538615A5 - - Google Patents
Info
- Publication number
- JP2024538615A5 JP2024538615A5 JP2024519447A JP2024519447A JP2024538615A5 JP 2024538615 A5 JP2024538615 A5 JP 2024538615A5 JP 2024519447 A JP2024519447 A JP 2024519447A JP 2024519447 A JP2024519447 A JP 2024519447A JP 2024538615 A5 JP2024538615 A5 JP 2024538615A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- conjugate
- tau
- administration
- weeks
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163261793P | 2021-09-29 | 2021-09-29 | |
| US63/261,793 | 2021-09-29 | ||
| PCT/US2022/077279 WO2023056369A1 (en) | 2021-09-29 | 2022-09-29 | Method of safe administration of tau phosphopeptide conjugate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024538615A JP2024538615A (ja) | 2024-10-23 |
| JP2024538615A5 true JP2024538615A5 (cg-RX-API-DMAC7.html) | 2025-10-09 |
Family
ID=85783654
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024519447A Pending JP2024538615A (ja) | 2021-09-29 | 2022-09-29 | タウホスホペプチドコンジュゲートの安全な投与の方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250049900A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4408864A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024538615A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240082368A (cg-RX-API-DMAC7.html) |
| CN (1) | CN118613496A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022356435A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3233247A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2024003775A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023056369A1 (cg-RX-API-DMAC7.html) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102596236B (zh) * | 2009-07-30 | 2015-06-24 | 辉瑞疫苗有限责任公司 | 抗原性Tau肽及其用途 |
| TW202333768A (zh) * | 2017-10-25 | 2023-09-01 | 美商健生醫藥公司 | Tau胜肽之組成物及其用途 |
| MX2021012994A (es) * | 2019-04-24 | 2022-03-04 | Janssen Pharmaceuticals Inc | Administracion heterologa de vacunas tau. |
-
2022
- 2022-09-29 EP EP22877579.7A patent/EP4408864A4/en active Pending
- 2022-09-29 CA CA3233247A patent/CA3233247A1/en active Pending
- 2022-09-29 KR KR1020247013320A patent/KR20240082368A/ko active Pending
- 2022-09-29 CN CN202280078258.6A patent/CN118613496A/zh active Pending
- 2022-09-29 AU AU2022356435A patent/AU2022356435A1/en active Pending
- 2022-09-29 US US18/696,444 patent/US20250049900A1/en active Pending
- 2022-09-29 MX MX2024003775A patent/MX2024003775A/es unknown
- 2022-09-29 JP JP2024519447A patent/JP2024538615A/ja active Pending
- 2022-09-29 WO PCT/US2022/077279 patent/WO2023056369A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20200140488A1 (en) | Alzheimer's disease treatment method | |
| TWI379839B (en) | Aβ immunogenic peptide carrier conjugates and methods of producing same | |
| CN102596236B (zh) | 抗原性Tau肽及其用途 | |
| CN101384279B (zh) | 抗淀粉样蛋白免疫原性组合物、方法和用途 | |
| US20070134762A1 (en) | Immunogenic peptide carrier conjugates and methods of producing same | |
| AU2009257170A1 (en) | Compounds for treating symptoms associated with Parkinson's disease | |
| RU2007145052A (ru) | Композиции пептидного конъюгата и способы для профилактики и лечения болезни альцгеймера | |
| US20100028353A1 (en) | Anti-amyloid immunogenic compositions, methods and uses | |
| HUE027563T2 (en) | Use of mimotopes of alpha-synuclein epitopes in the treatment of Lewy body diseases | |
| JP2023541669A5 (cg-RX-API-DMAC7.html) | ||
| JP2022529529A5 (cg-RX-API-DMAC7.html) | ||
| TW202212348A (zh) | 用於治療阿茲海默症之β類澱粉蛋白疫苗 | |
| EP2659906A1 (en) | Compositions | |
| CN117751132A (zh) | 用于治疗阿尔兹海默氏病的tau疫苗 | |
| EP2659908A1 (en) | Compositions | |
| CN121001737A (zh) | Tau和β淀粉样肽免疫原组合物及相关方法 | |
| EP0597838A1 (en) | Vaccine compositions | |
| JP2024532787A5 (cg-RX-API-DMAC7.html) | ||
| CN119894531A (zh) | Tau肽免疫原构建体 | |
| CN121646476A (zh) | 用于治疗淀粉样变性的疫苗 | |
| JP2023508777A (ja) | インターロイキン-6に対して指向される免疫応答を誘導するための免疫原性複合体 | |
| WO2006097416A1 (en) | Compounds for use in the prevention and treatment of alzheimer's disease | |
| AU2011226926A1 (en) | Alzheimer's disease treatment method |